Rallybio Corporation shares rise 1.20% intraday after Morgan Stanley Global Healthcare Conference.

viernes, 5 de septiembre de 2025, 10:02 am ET1 min de lectura
RLYB--
Rallybio Corporation rose 1.20% in intraday trading. The company's stock price movement is not directly related to the news events provided, which primarily focus on other companies such as Recursion Pharmaceuticals, Johnson & Johnson, AstraZeneca, Halozyme Therapeutics, and Boston Scientific.

Rallybio Corporation shares rise 1.20% intraday after Morgan Stanley Global Healthcare Conference.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios